Australia markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
137.26-0.24 (-0.17%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
No. of analysts19192021
Avg. Estimate-1.76-1.79-5.99-4.2
Low estimate-2.45-2.87-8.57-8.37
High estimate-1.08-0.99-4.252.08
Year ago EPS-1.7-3.16-9.71-5.99
Revenue estimateCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
No. of analysts19192022
Avg. Estimate137.79M149.26M565.64M822.61M
Low estimate114.6M119.6M464.97M541M
High estimate205M217M1.19B1.4B
Year ago sales99.04M100.11M380.83M565.64M
Sales growth (year/est)39.10%49.10%48.50%45.40%
Earnings history29/09/201930/12/201930/03/202029/06/2020
Est. EPS-1.35-1.86-1.88-1.76
Actual EPS-1.7-3.16-0.23-1.93
Difference-0.35-1.31.65-0.17
Surprise %-25.90%-69.90%87.80%-9.70%
EPS trendCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
Current estimate-1.76-1.79-5.99-4.2
7 days ago-1.76-1.79-5.99-4.2
30 days ago-1.78-1.8-5.98-4.3
60 days ago-1.75-1.82-5.91-3.43
90 days ago-1.56-1.59-5.27-2.33
EPS revisionsCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2223
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSRPTIndustrySector(s)S&P 500
Current qtr.-3.50%N/AN/AN/A
Next qtr.43.40%N/AN/AN/A
Current year38.30%N/AN/AN/A
Next year29.90%N/AN/AN/A
Next 5 years (per annum)-0.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A